Your browser is no longer supported. Please, upgrade your browser.
AZN AstraZeneca PLC monthly Stock Chart
AZN [NASD]
AstraZeneca PLC
Index- P/E63.57 EPS (ttm)0.82 Insider Own0.50% Shs Outstand2.62B Perf Week-1.94%
Market Cap137.22B Forward P/E20.45 EPS next Y2.54 Insider Trans0.00% Shs Float2.60B Perf Month-4.01%
Income2.15B PEG3.31 EPS next Q0.44 Inst Own17.60% Short Float0.20% Perf Quarter-8.09%
Sales25.70B P/S5.34 EPS this Y-39.70% Inst Trans0.07% Short Ratio1.15 Perf Half Y1.01%
Book/sh4.66 P/B11.16 EPS next Y28.43% ROA3.60% Target Price59.73 Perf Year10.05%
Cash/sh2.32 P/C22.44 EPS next 5Y19.20% ROE17.80% 52W Range36.15 - 64.94 Perf YTD4.29%
Dividend1.40 P/FCF- EPS past 5Y1.00% ROI8.30% 52W High-19.93% Beta0.56
Dividend %2.69% Quick Ratio0.60 Sales past 5Y-1.70% Gross Margin80.30% 52W Low43.85% ATR1.01
Employees70600 Current Ratio0.80 Sales Q/Q7.80% Oper. Margin14.90% RSI (14)36.79 Volatility2.03% 1.59%
OptionableYes Debt/Eq1.61 EPS Q/Q481.10% Profit Margin8.40% Rel Volume1.25 Prev Close51.96
ShortableYes LT Debt/Eq1.28 EarningsNov 05 BMO Payout0.00% Avg Volume4.44M Price52.00
Recom1.60 SMA20-3.34% SMA50-5.07% SMA2000.62% Volume5,545,328 Change0.08%
Sep-29-20Initiated Berenberg Buy
Nov-22-19Initiated SVB Leerink Outperform
Oct-25-19Upgrade Liberum Hold → Buy
Apr-02-19Downgrade UBS Neutral → Sell
Feb-05-19Initiated Exane BNP Paribas Outperform
Jan-25-19Upgrade Shore Capital Hold → Buy
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Oct-26-20 02:14AM  
Oct-25-20 02:33PM  
03:03AM  
Oct-23-20 11:55PM  
11:09PM  
06:32PM  
03:54PM  
03:45PM  
03:04PM  
02:31PM  
02:23PM  
11:33AM  
10:40AM  
09:44AM  
06:14AM  
01:00AM  
Oct-22-20 04:51PM  
03:34PM  
01:59PM  
10:37AM  
10:19AM  
09:00AM  
06:05AM  
Oct-21-20 04:34PM  
04:12PM  
04:00PM  
03:50PM  
02:16PM  
01:58PM  
01:33PM  
12:14PM  
10:46AM  
09:30AM  
04:34AM  
12:35AM  
Oct-20-20 06:41PM  
04:27PM  
02:58PM  
02:46PM  
12:47PM  
12:45PM  
10:52AM  
10:49AM  
10:12AM  
08:01AM  
07:12AM  
Oct-19-20 05:45PM  
09:09AM  
06:54AM  
02:23AM  
Oct-18-20 07:01PM  
Oct-17-20 08:09AM  
07:40AM  
07:07AM  
Oct-16-20 03:24PM  
01:53PM  
01:26PM  
09:57AM  
08:23AM  
07:58AM  
04:59AM  
Oct-15-20 11:59AM  
09:41AM  
Oct-14-20 04:44PM  
04:29PM  
04:22PM  
12:22PM  
11:45AM  
11:14AM  
09:31AM  
09:18AM  
08:38AM  
08:17AM  
08:00AM  
Oct-13-20 04:24PM  
04:18PM  
03:56PM  
03:30PM  
03:20PM  
12:10PM  
11:35AM  
11:20AM  
10:37AM  
09:12AM  
08:45AM  
08:12AM  
Oct-12-20 11:24PM  
07:12PM  
05:49PM  
05:45PM  
04:17PM  
04:15PM  
03:55PM  
02:44PM  
01:53PM  
01:02PM  
11:38AM  
11:31AM  
10:23AM  
08:31AM  
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.